A total of 54 adult patients with chronic intestinal or hepato-intestinal schis tosomiasis mansoni were included into a double-blind clinical trial to compare praziquantel and oxamniquine. Following a randomized allocation, 27 patients received praziquantel -65 mg/kg bwt -and 27 oxamniquine -18 mg/kg bwtin a single oral dose divided into two intakes. The incidence, severity and du ration of side-effects were similar for the two drugs.
INTRODUCTION
Oxamniquine, a 2 aminomethyl tetrahydroquinoleine derivative, was selected by BAXTER and RICHARDS in 1971 as one of the most pro mising schistosomicidal agents 2 .
Several authors, mainly in Brazil, have re ported excellent therapeutical results with this drug in mansoni schistosomiasis despite va riable cure rates administering similar doses, either to adults or to children, and using the same parasitological evaluation method (stool examination according to Kato Katz) 441,21,27,28, On the other hand, when we investigated through the quantitative oogram technique the efficacy of oxamniquine in a single dose of 15 to 18 mg/kg bwt in adult patients living away from any focus of this infection, contrariwise to the papers published so far, we found out a quite low (38%) cure rate' 2 . We concluded that although oxamniquine acts against Schis tosoma mansoni its activity is only transient. In most of the cases the drug reduced the worm burden but without being able to sup press the persistence of the parasitosis.
Praziquantel, a novel schistosomicidal agent, is a low toxicity isoquinoline-pyrazine compound active against all schistosome spe cies pathogenic to man, namely S. mansoni, S. haematobium and S. japonicum i.i6,n,36. More over, in the treatment of experimental as well as human schistosomiasis this drug proved to be highly efficatious 7,8,14,19,22,23,30,31,33.
Double-blind clinical trials comparing pra ziquantel with oxaminiquine in single doses ha ve been carried out as well, revealing no signi ficant difference between their efficacy in accordance with the evaluation by stool exami nations following the KatoKatz method 5,15,
24,25.
On the other hand, in consequence of di vergent findings attained by us with oxamni quine in previous therapeutical evaluation ba sed on the quantitative oogram, we decided to undertake a double blind clinical trial using this same technique to compare these two antisehistosome agents. In addition stool exami nation according to both, Hoffmann, Pons & Janer and Kato-Katz methods, were performed to confront the accuracy of these different pa rasitological methods in the diagnosis and in the assessment of therapeutical efficacy.
PATIENTS AND METHODS
A total of 54 patients, 52% males and 48% females, in between 15 and 55 years of age, weighting from 38 to 86 kg, were forwarded to our out patient clinical having a previously po sitive stool examination for S. mansoni eggs. They presented the intestinal (54%) or hepato intestinal (46%) form of chronic schistoso miasis and have not been treated yet with any speciifc medication. All of them lived in the city of Belo Horizonte, away from contact -with any focus of this infection and they were ins tructed not to return to endemic areas during the six months subsequent to the treatment. Pregnant or nursing women, patients with as sociated liver, kidney, lung or heart disease, acute or severe chronic illnesses, as well as marked anemia or nutritional deficiencies, were excluded from the trial.
Following the parallel group design, the patients upon entering the trial were allocat ed into one of two groups which distribution according to age, sex body weight, clinical form of the disease and worm burden (as determin ed by the quantitative oogram findings) is dis closed in Table I . Both groups had an equal number of cases (27 patients) and were homo geneous regarding these features.
One was treated with praziquantel and the other with oxamniquine, in accordance with a double blind administration. The two drugs were dispensed in individually coded bottles and presented in capsules of identical appearence but containing different dosages -praziquantel 325 mg and oxamniquine 90 mg. Therefore, the number of capsules to be taken in relation to each pa tient's bodyweight was the same for either drug to reach an average dose of 65 mg/kg and 18 mg/kg, respectively. The total medication was administered in a single dose divided into two intakes, four hours apart, always at morn ing, under the direct supervision of the nurses. The double-blind code was provided prior to the beginning of the study within sealed enve-lopes, for each case, to be opened only at the end of the trial.
Prior to treatment all patients were sub mitted to rectal mucosa biopsy for performing a quantitative oogram 6 . Except for eight cases in whom the number of living S. mansoni eggs per gram of tissue ranged from 1,085 to 1,926, all others had more than 2.000 eggs. The stool examination was repeated according to the spontaneous sedimentation HOFFMAN, PONS & JANER 13 method (HPJ) and the quan titative Kato method modified by KATZ 20 (K-K). The former was performed along the established classical procedures and the latter using the Vermifec® kit from Boehringer Mannheim. Three slides were taken of each stool sample and the arithmetical mean of the countings indicated the result of the examina tion. As demonstrated in Table II , whereas the HPJ was positive in all cases in relation to the oogram results, the KK was positive only in 35.2% of them.
The control of parasitological cure at the end of 1, 2, 4 and 6 months after the drug administration included quantitative oogram evaluation, as well as stool examinations in conformity to both aforementioned methods. In addition, rectal mucosa biopsies were taken on the 6th. and 18th. days following the treat ment, in a limited number of patients, that is, 9 patients with the praziquantel and 5 patients with the oxamniquine, to verify the immediate effect of the therapy and its coefficient of va riation 9 .
On the day of treatment the patients under went a thorough physical examination and re mained under observation during six to eight hours after the drug intake to look for any ad verse drug reaction. Two days afterwards they returned to the outpatient clinic to be investi gated concerning the occurrence of late side-ef fects.
RESULTS
Tolerability -The occurrence of sideeffects is displayed in Table III . Their inciden ce, severity and duration were similar for both drugs. They occurred in 43% of the patients, were mostly (88%) of slight to moderate in tensity and did not last longer than four hours in 28% of the cases, than eight hours in 47% and than 24 hours in 98%. Usually (91%), they appeared within the first four hours subse quent to the drug intake and all of them disap peared spontaneously without any medication.
The main complaints were dizziness (24%), drowsiness (15%), heartburn (15%), general malaise (15%) and nausea (11%). The first two had a tendence to be more frequently ob served under oxamniquine and the last two under praziquantel. On the fifth day after taking this drug one patient developed eosinophic pneumonitis, Loefler Syndrome, diagnosed by X-Ray and laboratorial examinations.
Efficacy -In order to investigate the im mediate effect of the two drugs on the egg laying capacity of S. mansoni, quantitative oograms were performed on the 6th. and 18th. days after therapy in nine patients treated with praziquantel and in five with oxamniquine. The method's coefficient of variation (CV) was then calculated. It ranged from 103 to 171% with the former drug and from 99 to 164% with the latter one, as shown in Table IV . The Graphics 1 2 and 3 illustrate three examples from the praziquantel group and Graphics 4, 5 and 6, three from the oxamniquine group. They also indicate the outcome of the treat ment, recurrence or cure, at the end of the six month follow up.
In the assessment of the therapeutical effi cacy it is noteworthy that the results in regard to the three parasitological control methods were not concordant. As observed, in Table V , in 24 patients who have completed the six month follow up out 27 treated with praziquan tel the cure rates were: 29.2% (7/24) according to the oogram; 50.0% (12/24) to the HPJ and 91.7% (22/24) to the K-K. In the 22 controlled patients out of 27 treated with oxamniquine these rates were 22.7% (5/22), 50.0% (11/22) and 86.3% (19/22), respectively.
On the other hand, the mean number of living eggs per gram of tissue taken by biopsy of the rectal mucosa prior to treatment in the two groups, 3,348, has decreased to 571 follow ing the drug administration, meaning a reduc tion of 83% in the worm burden, as indicated in Table VI (54 cases before the treatment and 112 cases with living eggs in the oograms after the treatment). Furthermore, the relationship between the number of living S. mansoni eggs found in the quantitative oograms and the positivity of the correspondent stool examinations, before as well as after treatment with either praziquan tel or oxamniquine, was established. It beca me evident, as displayed in Table VII , that there is a direct correlation between both tech niques; the greater the number of living eggs per gram of tissue taken by biopsy of the rec tal mucosa, the higher the percentage of posi tive findings in the stool examination. However. the K-K method showed a lower sensitivity than the HPJ method. When the number of eggs in the oorgram was above 2,000 the HPJ was positive in 100% of the cases but the K K in 25.6%, between 1,000 and 2,000 the HPJ was positive in 66.7% and the K-K in 9.1% below 1,000 the HPJ was positive in 38% and the K-K only in 6%.
Such correlation is also illustrated by Fi gure A for both treatment groups. It demons trates that the reduction in the number of li ving eggs in the oogram consequent to the treatment leads to a diminished positivity of the stool examinations. Again, the K-K is asso ciated with a higher degree of false negative results 92.9% than the HPJ method 47.3%.
DISCUSSION
Prom our point-of view the therapeutical evaluation of new drugs for treating human schistosomiasis mansoni should be accompli shed through the quantitative oogram via rec tal mucosa biopsies due to the trusfcworthness of this method W°.
The therapeutic effects of schistosomicides have an initial phase (shift of worms from me senteric veins to the liver) and a second phase (ensheathment, degeneration and phagocytosis in the liver) which depends upon the time the worms are in the liver. If the worms are not killed, remigration to the mesenteric veins will occur. Since there is normally a continuity in the process of egg-laying by females, the first result of an active drug is to cause interruption of oviposition with consequent alterations in the oogram. Because no drug acts on the eggs themselves they continue their development in the tissue up to maturation and elimination in the stools. After some time no immature egg is observed. If the effect of the drug is of short duration or temporary-just sufficient to pro duce a major shift of the worms from mesen teric veins to the liver-hut does not kill the worms, remigration to the mesenteric veins occurs and the oogram will show re establish ment of oviposition some time later, with reapperance of viable eggs, giving a picture o cli nical relapse. If this does not occur and the effect is definitive, there is cure. Indeed, if the suppresion lasts longer than six months a parasitological cure is achieved.
When the drug does not act on the worms -• i.e., when it is inactive -no alteration of the distribution of the worms in the portal sys tem is produced and the oogram will not chan ge; this is treatment failure.
Finally, some drugs are partially active During treatment some worms which did not shift to the liver may remain in the intestinal venules andi maintain oviposition, which of course, will be reduced. There is a significant reduction, both immature and mature living eggs but not their disappearence in the oograms subsequent to the treatment.
In case of either a partially or a transient active drug, modifications whithin the chemical structure of the substance could be made in order to obtain a definitive active anti-schistosome agent.
Under this standpoint and taking into account the results of our clinical trial, both drugs have proved to be partial or transient active substances against S. mansoni infection, although in the few cured cases their action has been a definitive one. Actually, we already had demonstrated this fact in regard to oxam niquine 11,12,27. The current findings showing a C.V. greater than 60% (from 99 to 164%) have confirmed it once again. Praziquantel was a potent agent being able to interrupt egg laying in practically all patients with a C.V. rangeing from 103 to 171%. Solely in one case there was an incomplete egg laying suppression, immature living eggs being found until the 18th. day after the drug intake, in spite of a C.V. of 127% (Table IV) . Considering the results of previous experimental studies involving praziquantel 3-26 , we believe that it would be feasible to render it a definitive acting schistosomicidal agent in almost all cases if its administration is prolonged beyond a single day treatment using this same daily dose. To confirm such assumption would mean an important objective, particularly in view of this drug being active against S. mansoni strains resistant to oxamniquine 13 .
At the end of the six month follow up the cure rates according to the oogram findings were 29% with praziquantel and 23% with oxamniquine, that is, a recurrence rate of 71% and 77%, respectively. It should be emphasized that although these cure rates were quite low, there was a marked decrease (83%) in the mean number of living eggs in the non-cured cases, leaving no doubt about an obvious reduction of the parasitic load induced by the treatment with either drug. Hence, the efficacy of the two agents was similar, in agreement with reports from other investigators 5,15,24,25, However, the recurrences observed after oxamniquine occurred invariably between the first and second months whilst it took a little longer, between the second and third months, after praziquantel. Since all patients did not came into contact with any focus of this infection during the parasitological control period, one can dismiss the possibility of reinfections.
The oograms in the cured patients showed absence of living eggs and reduction or sometimes disappearence of dead ones. Firstly the recently dead, then the calcified eggs and later the granulomas disappeared. In the noncured case, dead eggs -recently and calcified ones as well as granulomas -were always present besides the living eggs.
On the other hand, in accordance with stool examinations the cure rates were: 50% for both drugs using the HPJ method; 92% with praziquantel and 86% with oxamniquine using the K-K method. Therefore, a clear differencein the percentage of cure was observed amongst the three methods. The oogram proved to be the most accurate one, followed by HPJ and lastly by K-K.
Prior to therapy, the oogram and the HPJ were positive in 100% of the cases but the KrK only in 35%. Since the positivity of the stool examinations correlates directly with the number of living eggs in the oogram, ¿he accuracy of both HPJ and K-K has diminished markedly following the sharp fall of these eggs caused by treatment. For 112 (110%) positive oograms subsequent to therapy, the HPJ was positive in only 53% of the cases and the K-K in no more than 7%. Due to this rather high frequency of false-negative results (93,0%) observed with KK, a question is rased on the validityof using this method in clinical trials to establish the efficacy of new drugs.
Confronting our results, according to the oogram findings, with those from other investigations based on stool examinations, a remarkable difference in the therapeutical efficacy becomes evident. Such discrepancy in cure rates already has been pointed out in our previous study involving oxamniquine 12 . Concerning praziquantel, several authors have re-ported relatively high cure rates: 84.4% with 2 x 25 mg/kg in hepatosplenic cases8; 92.0% with 1 x 50 mg/kg and 97.0% with 3 x 20 mg/kg22; 93.3% in acute cases and 87.5% in chronic ones with 2 x 25 mg/kg94.4% with 1 x 40 mg/kg in hepatosplenic cases 33 . If we also would rely solely on the figures from the K-K method the cure rate achieved in our study, 91.7%, is similar to these. Consequently, we may infer that the divergence between our therapeutical results, either with praziquantel or oxamniquine, and those refered by other investigators, stem from the different accuracy of the applied methodology for assessing parasitological cure.
In our opinion, the quantitative oogram is the most reliable technique for the evaluation of new schistosomicidal agents in man and a methodological uniformity regarding the parasitológica! control of cure should be reached to avoid divergent interpretations about therapeutical efficacy of drugs. Ambas as drogas provaram ser ativas contra o esquistossoma, vez que os respectivos coeficientes de variação, determinados a partir de oogramas efetuados imediatamente após o tratamento, foram superiores a 60%. Ademais, dentre os 27 pacientes de cada grupo, 24 tratados com praziquantel e 22 com oxamniquine completaram o período de seis meses, requerido para controle parasitológico.
RESUMO
Os índices de cura, segundo os achados do oograma e dos exames de fezes pelos métodos de HPJ e KK, foram, respectivamente, 29%,-50% e 92% com o praziquantel; 23%, 50% e 86% com a oxamniquine. Apesar do baixo percentual de cura, observou-se nos oogramas pós tratamento, uma pronunciada queda no número de ovos vivos por grama de tecido.
Esses resultados revelam que ambas as drogas foram semelhantemente eficazes, embora já se tenha comprovado que a susceptibili¬ dade do S. mansoni não seja sempre igual para cada um desses medicamentos, pois linhagens resistentes à oxamniquine evidenciaram ser 100% sensíveis ao praziquantel.
Por outro lado, constatou-se uma nítida diferença nos percentuais de cura em função do método utilizado para controle parasitológico. O oograma foi o mais preciso, seguido pelo HPJ e, finalmente, pelo K-K. Tendo ocorrido uma correlação direta entre o número de ovos vivos no oograma e a positividade dos exames de fezes, a percentagem de resultados falso-negativos aumentou acentuadamente após o tratamento, alcançando 47,3% com o HPJ e 92,9% com o K-K. Antes da medicação esses índices eram, respectivamente, 0% e 64,8%.
Os autores depreendem que a diferença de precisão da metodologia aplicada para avaliar a eficácia terapêutica pode explicar a divergência encontrada entre o índice de cura obtido neste -ensaio clínico e os relatados por outros investigadores, tanto com o praziquantel quanto com a oxamniquine.
